Bringing Antimicrobial Susceptibility Testing for New Drugs into the Clinical Laboratory: Removing Obstacles in Our Fight against Multidrug-Resistant Pathogens

James E. Kirby, Thea Brennan-Krohn, Kenny SmithJournal of Clinical Microbiology 2019 · DOI

Abstract

There are now several new antibiotics available to treat multidrug-resistant pathogens, and susceptibility testing methods for these drugs are increasingly available at the time of drug approval. However, lack of clarity regarding verification requirements remains a formidable barrier to introducing such testing in clinical laboratories, making these drugs practically unavailable for patient use. We propose a change in the framework for bringing in testing for new antibiotics, focusing on quality control rather than underpowered verification studies.
BibTeX
@article{kirby2019bringing,
  author = {James E. Kirby and Thea Brennan-Krohn and Kenny Smith},
  title = {{Bringing Antimicrobial Susceptibility Testing for New Drugs into the Clinical Laboratory: Removing Obstacles in Our Fight against Multidrug-Resistant Pathogens}},
  journal = {Journal of Clinical Microbiology},
  year = {2019},
  doi = {10.1128/jcm.01270-19},
}

Loading related content...

Figure